The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN
ALK 抑制剂 PF-06463922 作为单一药物，可有效治疗由 ALK 和 MYCN 表达驱动的神经母细胞瘤
期刊:Disease Models & Mechanisms
影响因子:4
doi:10.1242/dmm.024448
J Guan, E R Tucker, H Wan, D Chand, L S Danielson, K Ruuth, A El Wakil, B Witek, Y Jamin, G Umapathy, S P Robinson, T W Johnson, T Smeal, T Martinsson, L Chesler, R H Palmer, B Hallberg
